March Altus Capital Management’s DexCom DXCM Stock Holding History

March Altus Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.25M	Buy	56,800 +10,000	+21%	+$223K	7.79%	5
2016 Q2	$928K	Sell	46,800 -29,384	-39%	-$500K	7.17%	8
2016 Q1	$1.29M	Hold	76,184	–	–	13.38%	3
2015 Q4	$1.56M	Buy	76,184 +37,008	+94%	+$770K	14.35%	4
2015 Q3	$841K	Sell	39,176 -22,840	-37%	-$510K	4.95%	6
2015 Q2	$1.24M	Sell	62,016 -3,312	-5%	-$58.2K	7.21%	4
2015 Q1	$1.02M	Sell	65,328 -1,002,976	-94%	-$15.2M	6.4%	9
2014 Q4	$14.7M	Sell	1,068,304 -469,908	-31%	-$5.75M	6.72%	2
2014 Q3	$15.4M	Sell	1,538,212 -50,848	-3%	-$520K	6.12%	3
2014 Q2	$15.8M	Sell	1,589,060 -1,206,280	-43%	-$10.7M	5.77%	4
2014 Q1	$28.9M	Sell	2,795,340 -544,012	-16%	-$5.62M	9.28%	1
2013 Q4	$29.6M	Buy	+3,339,352	New	+$26.4M	8.95%	1

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

March Altus Capital Management's DXCM Position: Q3 2016 in Review

March Altus Capital Management increased its DexCom (DXCM) stake by 21% in Q3 2016, buying an estimated $223K and bringing the position to 56,800 shares worth $1.25M. The position accounts for 7.79% of the portfolio, ranked #5.

March Altus Capital Management first reported a position in DXCM in Q4 2013 and has held it in 12 quarters since. The position peaked at $29.6M in Q4 2013. 290 funds tracked by Wall St. Rank hold DXCM as of Q3 2016.

March Altus Capital Management held 56,800 shares of DexCom worth $1.25M as of Q3 2016.
March Altus Capital Management bought 10,000 DexCom shares in Q3 2016, an estimated $223K.
DexCom made up 7.79% of March Altus Capital Management's portfolio in Q3 2016, its #5 holding.
March Altus Capital Management first reported a position in DexCom in Q4 2013 and has held it in 12 quarters since.
March Altus Capital Management's DexCom position peaked at $29.6M in Q4 2013.
290 funds tracked by Wall St. Rank held DexCom as of Q3 2016.

Based on March Altus Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.